200 related articles for article (PubMed ID: 2445781)
1. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa.
Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ
J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781
[TBL] [Abstract][Full Text] [Related]
2. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ
J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225
[TBL] [Abstract][Full Text] [Related]
3. GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes.
Dancis A; Ehmann C; Ferziger R; Grima K; Karpatkin S
Blood; 1988 Apr; 71(4):1056-61. PubMed ID: 3355887
[TBL] [Abstract][Full Text] [Related]
4. Studies on the nature of the human platelet alloantigen, PlA1: localization to a 17,000-dalton polypeptide.
Newman PJ; Martin LS; Knipp MA; Kahn RA
Mol Immunol; 1985 Jun; 22(6):719-29. PubMed ID: 2410782
[TBL] [Abstract][Full Text] [Related]
5. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
Newman PJ; Derbes RS; Aster RH
J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
[TBL] [Abstract][Full Text] [Related]
6. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope.
Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S
Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.
Liu LX; Nardi MA; Flug F; Karpatkin S
Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161
[TBL] [Abstract][Full Text] [Related]
8. Different specificities of platelet-associated and plasma autoantibodies to platelet GPIIb-IIIa in patients with chronic immune thrombocytopenic purpura.
Fujisawa K; Tani P; O'Toole TE; Ginsberg MH; McMillan R
Blood; 1992 Mar; 79(6):1441-6. PubMed ID: 1547343
[TBL] [Abstract][Full Text] [Related]
9. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets.
Khaspekova SG; Vlasik TN; Byzova TV; Vinogradov DV; Berndt MC; Mazurov AV
Br J Haematol; 1993 Oct; 85(2):332-40. PubMed ID: 7506568
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of the platelet-specific alloantigen Leka: a comparative study with the PlA1 alloantigen.
Kieffer N; Boizard B; Didry D; Wautier JL; Nurden AT
Blood; 1984 Dec; 64(6):1212-9. PubMed ID: 6208952
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of platelet surface alloantigens using a monoclonal probe.
Janson M; McFarland J; Aster RH
Hum Immunol; 1986 Mar; 15(3):251-62. PubMed ID: 3754249
[TBL] [Abstract][Full Text] [Related]
12. The platelet alloantigen Zwa or PlA1 is expressed by cultured endothelial cells.
Leeksma OC; Giltay JC; Zandbergen-Spaargaren J; Modderman PW; van Mourik JA; von dem Borne AE
Br J Haematol; 1987 Jul; 66(3):369-73. PubMed ID: 3620355
[TBL] [Abstract][Full Text] [Related]
13. Blood group A antigen expression in platelets is prominently associated with glycoprotein Ib and IIb. Evidence for an A1/A2 difference.
Hou M; Stockelberg D; Rydberg L; Kutti J; Wadenvik H
Transfus Med; 1996 Mar; 6(1):51-9. PubMed ID: 8696448
[TBL] [Abstract][Full Text] [Related]
14. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes.
Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ
Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa.
Liu LX; Nardi MA; Casella JF; Karpatkin S
Blood; 1996 Nov; 88(9):3601-7. PubMed ID: 8896429
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3.
Newman PJ; Allen RW; Kahn RA; Kunicki TJ
Blood; 1985 Jan; 65(1):227-32. PubMed ID: 3155488
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response.
Valentin N; Visentin GP; Newman PJ
Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638
[TBL] [Abstract][Full Text] [Related]
18. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes.
Liu LX; Nardi M; Flug F; Karpatkin S
Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia.
Kunicki TJ; Pidard D; Cazenave JP; Nurden AT; Caen JP
J Clin Invest; 1981 Mar; 67(3):717-24. PubMed ID: 7193688
[TBL] [Abstract][Full Text] [Related]
20. Posttransfusion purpura associated with an autoantibody directed against a previously undefined platelet antigen.
Stricker RB; Lewis BH; Corash L; Shuman MA
Blood; 1987 May; 69(5):1458-63. PubMed ID: 3567361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
